Cover ImageSALE
Market Research Report

Global Needle-Free Drug Delivery Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 517144
Published Content info 70 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Needle-Free Drug Delivery Market 2017-2021
Published: June 14, 2017 Content info: 70 Pages
Description

About Needle Free Drug Delivery

Needle free drug delivery technologies are used to deliver biologics such as insulin, vaccines, human growth hormone (HGH), and drugs for pain management into the patient's body without using a traditional needle. Needle free drug delivery market includes jet injectors, transdermal drug delivery systems and other novel needle free devices that are used as alternatives to conventional needle drug delivery devices.

Technavio's analysts forecast the global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global needle free drug delivery market for 2017-2021. To calculate the market size, the report considers sales and value.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Endo Pharmaceuticals
  • Antares Pharma
  • Inovio Pharmaceuticals
  • Valeritas
  • PharmaJet

Other Prominent Vendors

  • 3M
  • Akra Dermojet
  • Consort Medical
  • CROSSJECT
  • Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
  • PenJet Corporation
  • Zosano
  • D'Antonio Consultants International
  • European Pharma Group

Market driver

  • Increasing incidence of needle stick injuries
  • For a full, detailed list, view our report

Market challenge

  • Technical complexities of needle free drug delivery devices
  • For a full, detailed list, view our report

Market trend

  • Increasing outsourcing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR13559

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product/technology

  • Jet injectors
  • Market size and forecast
  • Transdermal drug delivery systems
  • Market size and forecast
  • Others
  • Market size and forecast

PART 07: Market segmentation by application

  • Market segmentation by application
  • Insulin delivery
  • Vaccination
  • Pain management
  • Others

PART 08: Geographical segmentation

  • Market overview
  • Americas
  • EMEA
  • APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Technological innovations
  • Increasing outsourcing
  • M&A and strategic collaborations

PART 12: Vendor landscape

  • Competitive scenario

PART 13: Key vendor analysis

  • Endo Pharmaceuticals
  • Antares Pharma
  • Inovio Pharmaceuticals
  • Valeritas
  • PharmaJet
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global needle free drug delivery market: Segmentation overview
  • Exhibit 02: Global needle free drug delivery market 2016-2021 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global needle free drug delivery market by product/technology
  • Exhibit 05: Global needle free drug delivery market share by product/technology 2016 (%)
  • Exhibit 06: Jet injectors in market
  • Exhibit 07: Jet injectors in development
  • Exhibit 08: Global jet injectors market 2016-2021: Overview
  • Exhibit 09: Global jet injectors market 2016-2021 ($ billions)
  • Exhibit 10: Microneedle drug delivery systems in market
  • Exhibit 11: Microneedle drug delivery systems in development
  • Exhibit 12: Iontophoresis drug delivery systems in market
  • Exhibit 13: Global transdermal drug delivery systems market 2016-2021: Overview
  • Exhibit 14: Global transdermal needle free drug delivery systems market 2016-2021 ($ billions)
  • Exhibit 15: Other drug delivery systems in market
  • Exhibit 16: Global other needle free drug delivery devices market 2016-2021 ($ billions)
  • Exhibit 17: Global needle free drug delivery market by application
  • Exhibit 18: Global needle free drug delivery market share by application 2016 (%)
  • Exhibit 19: Needle free insulin delivery systems in market
  • Exhibit 20: Needle free insulin delivery systems in development
  • Exhibit 21: Needle free vaccine delivery systems in market
  • Exhibit 22: Needle free vaccine delivery systems in development
  • Exhibit 23: Global needle free drug delivery market by geography 2016 (%)
  • Exhibit 24: Needle free drug delivery market in Americas 2016-2021 ($ billions)
  • Exhibit 25: Needle free drug delivery market in EMEA 2016-2021 ($ billions)
  • Exhibit 26: Needle free drug delivery market in APAC 2016-2021 ($ billions)
  • Exhibit 27: Endo International: Key highlights
  • Exhibit 28: Endo International: Strength assessment
  • Exhibit 29: Endo International: Strategy assessment
  • Exhibit 30: Endo International: Opportunity assessment
  • Exhibit 31: Antares Pharma: Key highlights
  • Exhibit 32: Antares Pharma: Strength assessment
  • Exhibit 33: Antares Pharma: Strategy assessment
  • Exhibit 34: Antares Pharma: Opportunity assessment
  • Exhibit 35: Inovio Pharmaceuticals: Key highlights
  • Exhibit 36: Inovio Pharmaceuticals: Strength assessment
  • Exhibit 37: Inovio Pharmaceuticals: Strategy assessment
  • Exhibit 38: Inovio Pharmaceuticals: Opportunity assessment
  • Exhibit 39: Valeritas: Key highlights
  • Exhibit 40: Valeritas: Strength assessment
  • Exhibit 41: Valeritas: Strategy assessment
  • Exhibit 42: Valeritas: Opportunity assessment
  • Exhibit 43: PharmaJet: Key highlights
  • Exhibit 44: PharmaJet: Strength assessment
  • Exhibit 45: PharmaJet: Strategy assessment
  • Exhibit 46: PharmaJet: Opportunity assessment
Back to Top